Recession shines light on inventory

Reducing inventory is the top action manufacturers have taken in response to the recession, as reported by more than half of respondents to a survey. Findings in the Aberdeen study show that 91 percent of companies indicate that they are reviewing opportunities to improve inventory performance through process change. Some 61 percent say they have made, or have been asked to make, inventory-related technology recommendations within the past six months. Release

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.